BookSurveen Ghumman, editor.
Contents:
1. Detection of ovulation and aetiology of anovulation
2. Evaluation prior to controlled ovarian stimulation
3. Therapeutic intervention of endometrial pathology before ovarian stimulation
4. Obesity and its impact on ovarian stimulation
5. Oral ovulogens in IUI and IVF
6. Ovarian stimulation in IUI
7. Protocols for gonadotropin use
8. Human menopausal gonadotropin, pure FSH, and recombinaant FSH: a comparative analysis
9. GnRH agonists in controlled ovarian stimulation
10. GnRH antagonist in ovarian stimulation
11. GnRH agonist versus antagonist in ART
12. Mild stimulation protocol
13. Individualizing ovarian stimulation protocols in ART
14. Impact of mutations and polymorphisms of gonadotrophins and their receptors on the outcome of controlled ovarian stimulation
15. The role of androgens in controlled ovarian stimulation
16. The role of LH in controlled ovarian stimulation
17. Ovulation trigger: HCG vs. GnRH agonist
18. The pharmacoeconomics of ovarian stimulation
19. Endocrine monitoring of ART cycles
20. Ultrasonography in controlled ovarian stimulation
21. Effect of ovarian stimulation on the endometrium
22. Luteal support: what to use when?
23. Endometrial support beyond hormones
24. Prediction of poor responders and current concepts in management
25. Premature rise of progesterone during ovarian stimulation
26. Empty follicle syndrome
27. Luteinizing unruptured follicle
28. Endometriosis: surgical management and optimal ovarian stimulation protocol for ART
29. Hyperprolactinemia
30. Polycystic ovarian syndrome and response to stimulation
31. Role of laparoscopic ovarian drilling in polycystic ovarian syndrome and its effect on ART
32. Ovulation induction in hypogonadotropic hypogonadism
33. Ovarian stimulation protocols in fertility preservation
34. Ovarian stimulation in cancer patient
35. Epidenetics and ovarian stimulation
36. Effect of ovarian stimulation protocols on oocyte and embryo quality
37. Ovarian hyperstimulation syndrome: can we eliminate it as a complication of ART?
38. Multifetal pregnancy reduction.